scholarly journals Cystic Craniopharyngioma with Spontaneous Shrinkage of the Cyst

1984 ◽  
Vol 24 (12) ◽  
pp. 954-957 ◽  
Author(s):  
Kaichi TOKIWA ◽  
Kenji NAKAYAMA ◽  
Yoshio MIYASAKA ◽  
Kuniaki MATSUMORI ◽  
Toshio BEPPU ◽  
...  
Keyword(s):  
Cystic Craniopharyngioma

scholarly journals Transcranial endoscopic management of pediatric cystic craniopharyngioma: Preliminary results

2021 ◽  
Vol 25 ◽  
pp. 101120
Author(s):  
Mohd. Kaif ◽  
Kuldeep Yadav ◽  
Amit Kumar Upadhyay ◽  
Deepak Kumar Singh ◽  
Rakesh Kumar Singh ◽  
...  
Keyword(s):  
Endoscopic Management ◽  
Preliminary Results ◽  
Cystic Craniopharyngioma

scholarly journals Unilateral Autosomal Recessive Anophthalmia in a Patient with Cystic Craniopharyngioma

2014 ◽  
Vol 38 (3) ◽  
pp. 149-152
Author(s):  
Amandeep Kumar ◽  
Ankit Bansal ◽  
Ajay Garg ◽  
Bhawani S. Sharma
Keyword(s):  
Autosomal Recessive ◽  
Cystic Craniopharyngioma

scholarly journals Neuroendoscopic Transventricular Surgery for Suprasellar Cystic Mass Lesions Such as Cystic Craniopharyngioma and Rathke Cleft Cyst

2004 ◽  
Vol 44 (8) ◽  
pp. 408-415 ◽  
Author(s):  
Yukiko NAKAHARA ◽  
Hisao KOGA ◽  
Kenji MAEDA ◽  
Masashi TAKAGI ◽  
Kazuo TABUCHI
Keyword(s):  
Cystic Mass ◽  
Cystic Craniopharyngioma ◽  
Rathke Cleft Cyst ◽  
Mass Lesions

scholarly journals Endoscopic transcortical transventricular management of cystic craniopharyngioma: Outcome analysis of 32 cases at a tertiary care center

2020 ◽  
Vol 15 (4) ◽  
pp. 846
Author(s):  
Somil Jaiswal ◽  
Manish Jaiswal ◽  
Pooja Jaiswal ◽  
Ankur Bajaj ◽  
Chhitij Srivastava ◽  
...  
Keyword(s):  
Care Center ◽  
Tertiary Care ◽  
Outcome Analysis ◽  
Tertiary Care Center ◽  
Cystic Craniopharyngioma

Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma

2007 ◽  
Vol 107 (4) ◽  
pp. 318-323 ◽  
Author(s):  
Lucie Lafay-Cousin ◽  
Ute Bartels ◽  
Charles Raybaud ◽  
Abhaya V. Kulkarni ◽  
Sharon Guger ◽  
...  
Keyword(s):  
Cystic Craniopharyngioma

scholarly journals Giant Cystic Craniopharyngioma: Case Report

1979 ◽  
Vol 6 (3) ◽  
pp. 363-365 ◽  
Author(s):  
Dwight Parkinson ◽  
Michael West
Keyword(s):  
Case Report ◽  
Ct Scan ◽  
Cystic Craniopharyngioma

SUMMARY:This is a report of a giant cystic craniopharyngioma which escaped diagnosis for nine years in spite of seemingly thorough neuroradiological investigation, prior to the advent of the CT scan.

scholarly journals Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon

2011 ◽  
Vol 69 (1) ◽  
pp. 50-55 ◽  
Author(s):  
Patrícia Alessandra Dastoli ◽  
Jardel Mendonça Nicácio ◽  
Nasjla Saba Silva ◽  
Andrea Maria Capellano ◽  
Silvia R.C. Toledo ◽  
...  
Keyword(s):  
Side Effects ◽  
Interferon Alpha ◽  
Tumor Volume ◽  
Response To Treatment ◽  
Lower Percentage ◽  
Intratumoral Chemotherapy ◽  
Cystic Craniopharyngioma ◽  
Tumor Reduction ◽  
One Year

OBJECTIVE: To assess whether the cystic craniopharyngiomas can be controlled with the use of intratumoral applications of interferon alpha. METHOD: Nineteen patients with the diagnosis of cystic craniopharyngioma were treated with intratumoral chemotherapy with interferon alpha from January 2002 to April 2006. All patients underwent placement of an intracystic catheter connected to an Ommaya reservoir. Through this reservoir were made applications during chemotherapy cycles. Each cycle corresponded to application of 3,000,000 units of interferon alpha three times per week on alternate days totalizing 36,000,000 units. Response to treatment was evaluated by calculating the tumor volume on MRI control after one, three and six months after the end of each cycle. Patients who developed worsening of symptoms or who had insignificant reduction in tumor volume during follow-up underwent repeat cycle chemotherapy. RESULTS: Four patients received four cycles of chemotherapy, three patients received three cycles, six patients received two cycles and six patients received one. The lower percentage of reduction in tumor volume was 60% and the bigger reduction was 98.37%. Eleven patients had a reduction greater than 90%. Five patients had a tumor reduction between 75 and 90% and in three patients the tumors were reduced by less than 75%. No deaths occurred during treatment and side effects of interferon alpha were well tolerated. No treatment was discontinued. Follow-up after the last application ranged from one year and five months to three years and nine months. CONCLUSION: The intratumoral chemotherapy with interferon alpha decreases the volume of cystic craniopharyngiomas and so far can be considered a new therapeutic alternative.

Sign in / Sign up

Export Citation Format

Share Document